Clinical Trial

Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 28, 2025 (before its estimated January 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to determine the value of Pentoxifylline for nephroprotection in these neonates with perinatal asphyxia, using cystatin C, regional oxygenation measured near infrared spectroscopy and renal Doppler sonography.
Trial Details
NCT Number NCT07088328
Lead Sponsor Alexandria University
Conditions Hypoxic-Ischemic Encephalopathy, Neonatal Encephalopathy, Pentoxifylline Adverse Reaction
Enrollment 30 participants
Start Date 2025-07-30
Primary Completion 2026-01-30 (estimated)
Study Completion 2026-03-02 (estimated)
Updated on ClinicalTrials.gov 2025-07-28